Disease
|
Drug/Important Bio-Agent (IBA)
10 | Antiviral Agents (Antivirals)IBA
04/2024
-
07/2004 |
9 | SimeprevirIBA
06/2020
-
05/2015 |
6 | Protease Inhibitors (Protease Inhibitor)IBA
12/2017
-
08/2011 |
3 | adafosbuvirIBA
06/2020
-
01/2018 |
3 | odalasvirIBA
06/2020
-
12/2018 |
2 | 27- cyclohexyl- 12,13,16,17- tetrahydro- 22- methoxy- 11,17- dimethyl- 10,10- dioxide- 2,19- methano- 3,7:4,1- dimetheno- 1H,11H- 14,10,2,9,11,17- benzoxathiatetraazacyclo docosine-8,18(9H,15H)-dioneIBA
02/2017
-
01/2017 |
2 | GSK2336805IBA
02/2017
-
01/2017 |
2 | Ritonavir (Norvir)FDA Link
02/2017
-
01/2017 |
2 | Chloroquine (Aralen)FDA LinkGeneric
08/2009
-
10/2004 |
1 | SofosbuvirIBA
06/2020 |
1 | daclatasvirIBA
06/2020 |
1 | InterferonsIBA
01/2019 |
1 | Proteins (Proteins, Gene)FDA Link
01/2018 |
1 | NucleotidesIBA
01/2018 |
1 | ledipasvirIBA
12/2017 |
1 | sofosbuvir drug combination ledipasvirIBA
12/2017 |
1 | Ribavirin (Virazole)FDA LinkGeneric
02/2017 |
1 | NucleosidesIBA
01/2017 |
1 | pyridine N-oxideIBA
03/2006 |
1 | A-factor (Streptomyces)IBA
04/2005 |
1 | RNA (Ribonucleic Acid)IBA
04/2005 |
1 | Viral RNAIBA
04/2005 |
1 | Antimalarials (Antimalarial Agents)IBA
10/2004 |
1 | S-Nitroso-N-AcetylpenicillamineIBA
07/2004 |
1 | Nitric Oxide DonorsIBA
07/2004 |
|
Therapy/Procedure
|